Masitinib for treating amyotrophic lateral sclerosis [ID967]
Discontinued
Reference number: GID-TA10157
As you will be aware, the Department of Health has asked NICE to conduct an appraisal of masitinib for treating amyotrophic lateral sclerosis.
Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, the deadline for submissions is now expected to be early February 2018.